Episode 171: The Country with One of the Highest Rates of MS in the World with Dr. Pamela Valentine
RealTalk MS7 Joulu 2020

Episode 171: The Country with One of the Highest Rates of MS in the World with Dr. Pamela Valentine

Every day, 12 more Canadians are diagnosed with multiple sclerosis. Facing one of the highest MS rates in the world, spread across a geographically large country, the MS Society of Canada is the only national voluntary organization in Canada that supports cutting-edge MS research while providing services and support to more than 90,000 people living with MS. Joining me as my guest is Dr. Pamela Valentine, who is not only the president & CEO of the MS Society of Canada but also a multi-award winning neuroscientist. During our conversation, we'll be talking about COVID-19, progressive MS, and some of the most pressing issues facing the MS community today. We'll also share some encouraging stem cell clinical trial results. (And we're including a quick review of what these different types of stem cells are all about!) We'll tell you about a new immune cell discovery that helps explain the importance of the connection between the gut and the central nervous system. We're also talking about a new study from the Mayo Clinic that shows how a woman's pregnancies and the onset of menopause may influence the onset of progressive MS. And we'll tell you where to watch a 2020 MS Research Update from MS Research Australia. This video was produced especially for people affected by MS, and it's definitely worth watching! We have a lot to talk about! Are you ready for RealTalk MS??!

Beneficial effects of mesenchymal stem cell transplantation in active progressive MS 1:44

Gut Immune Cells May Play Key Role in MS 5:38

Pregnancies, Later Menopause Tied to Progressive MS Onset Age 10:44

$100M Program Aims to Improve Diversity in Clinical Trials 12:53

MS Research Australia: Progress in MS Research Update 2020 16:15

My interview with Dr. Pamela Valentine 17:59

Share this episode 31:55

Donate to the National MS Society COVID-19 Response Fund 32:15

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/171

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

MS Society of Canada

STUDY: Beneficial Effects of Autologous Mesenchymal Stem Cell Transplantation in Active Progressive Multiple Sclerosis STUDY: Gut Microbiota-Specific IgA-B Cells Traffic to the CNS in Active Multiple Sclerosis STUDY: Reproductive History and Progressive Multiple Sclerosis Risk in Women Email for info about Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program: DCTCDPinfo@nmfonline.org VIDEO: MS Research Australia: Progress in MS Research Update 2020

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 171
Guests: Dr. Pamela Valentine

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSActivist, MSSocietyCanada, MSResearchAust, Stemcells, RealTalkMS

Privacy Policy

Jaksot(505)

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Welcome back to the third and final part of our coverage of the 2026 ACTRIMS Forum. This week's episode bridges the gap between groundbreaking clinical research and the nuanced reality of living with ...

23 Helmi 35min

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Welcome back to Part Two of our coverage of the 2026 ACTRIMS Forum. This week, we shift our focus to emerging therapies and clinical insights that are re-shaping the future of MS care. From the latest...

16 Helmi 44min

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the A...

9 Helmi 33min

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investig...

2 Helmi 39min

Episode 439: Preventing MS with Dr. Bruce Bebo

Episode 439: Preventing MS with Dr. Bruce Bebo

The first coordinated global research strategy to prevent MS has been announced. This week, Dr. Bruce Bebo, the National MS Society's Executive Vice President and Chief Research & Medical Affairs Offi...

26 Tammi 32min

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

One of the more confusing aspects of MS is that it can present differently from one person to the next. A research team at University College London may have uncovered a reason for that when they iden...

19 Tammi 29min

Episode 437: Remembering David Mitchell

Episode 437: Remembering David Mitchell

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medicati...

12 Tammi 29min

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Scientists are expanding our understanding of MS at an unprecedented pace. This week, Dr. Leorah Freeman discusses why, as new discoveries and medications enter clinical practice, neurologists and MS ...

5 Tammi 34min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
tiedenaiset-podcast
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
puhu-muru
rss-pitaisko-erota
katilon-kahvitunti
meditaatiot-suomeksi
rss-pt-paahtio
rss-uplevel-by-sonja-hannus
rss-narsisti
rss-rakas-mielenterveyteni
audio-sport-juoksu
junnut-pelissa
rss-ehjaksi
rss-mighty-finland-podcast
rss-kuumilla-aalloilla
selviytyjat-tarinoita-elamasta
rss-duodecim-lehti